Hematology and Oncology Associates at BridgePoint — Tupelo, Mississippi

Hematology and Oncology Associates at BridgePoint is a clinical research site located in Tupelo, Mississippi, United States 38801.

Crixeo Clinical Trials Trust Score: 14/100 (FAILING). This profile has not yet been claimed by the site owner.

Hematology and Oncology Associates at BridgePoint has participated in 6 clinical trials.

Therapeutic areas: Pancreatic Adenocarcinoma, Carcinoma, Non-Squamous Non-Small Cell Lung, Colorectal Cancer.

Sponsors: ImmunoGenesis, Hoffmann-La Roche, Gilead Sciences.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Tupelo

Browse all research sites in Mississippi · View every site in Tupelo

Sponsor Feasibility Report

Trust Score: 14/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Hematology and Oncology Associates at BridgePoint?

Hematology and Oncology Associates at BridgePoint has a Crixeo Trust Score of 14/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Hematology and Oncology Associates at BridgePoint conducted?

Hematology and Oncology Associates at BridgePoint has 6 clinical trials on record. Their work covers Pancreatic Adenocarcinoma, Carcinoma, Non-Squamous Non-Small Cell Lung, Colorectal Cancer.

Is Hematology and Oncology Associates at BridgePoint accredited by Crixeo Clinical Trials?

Hematology and Oncology Associates at BridgePoint has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Hematology and Oncology Associates at BridgePoint?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.